Last scanned
Domain Age
Daily Visitors
Global Rank
Updated:
OPDIVO® (nivolumab) | Information for Healthcare Professionals
Learn more about OPDIVO® (nivolumab), a prescription medicine that treats certain types of cancers. Please see Indications and Important Safety Information.
This website is hosted with Bristol-Myers Squibb Company, which reserves the following IP addresses for opdivoinformationhcp.com: 165.89.235.20. Moreover, DNS used with this website include ns1.bms.com, ns2.bms.com, ns3.bms.com, ns4.bms.com. Subnet identifier ranges from 165.89.0.0 to 165.89.255.255. Classless Inter-Domain Routing (CIDR) is 165.89.0.0/16. ARIN net type is Direct Allocation.
Last scanned
Domain Age
Daily Visitors
Global Rank
ns1.bms.com
ns2.bms.com
ns3.bms.com
ns4.bms.com
{{value}}
2016-10-10
2024-10-10
CSC CORPORATE DOMAINS, INC.
{{value}}
The registrar of opdivoinformationhcp.com is CSC CORPORATE DOMAINS, INC. and the name expires on 2024-10-10. According to open source data, you can reach the owner at dns.admin@BMS.COM but please make sure you have a good reason for unsolicited messages. Their country of residence is United States of America.
N/A
N/A
6.9K
15.1K
N/A
N/A
N/A
N/A
N/A
N/A